Jun 15, 2021 to Jun 17, 2021
A new grant at Washington State University will allow undergraduate students from WSU, Eastern Washington University, Lewis-Clark State College, and Gonzaga University get real-world agricultural research experience.
The USDA National Institute for Food and Agriculture (NIFA) Research and Extension Experiences for Undergraduates (REEU) grant will put students to work on field research and lab work centered on crops, including visits to farms to talk with agricultural stakeholders.
The program will culminate in a final project that students will present to their peers and advisors. Students from all four institutions will be eligible to apply for the project, which will be hosted at WSU.
E-Mail
IMAGE: By slightly adjusting an enzyme s amino acids, it can live in completely different environments. view more
Credit: Dr Ulrike Kappler
Just a few changes to an enzyme s amino acids can be enough to dramatically change its function, enabling microbes to inhabit wildly different environments.
University of Queensland microbiologist Associate Professor Ulrike Kappler, led by an international team of researchers, made this discovery when investigating how Haemophilus influenzae bacteria colonise the human respiratory system. This disease-causing bacterium is supremely adapted to living in humans, so much so that they cannot survive anywhere else, Dr Kappler said. It turns out that one enzyme, MtsZ, is the key player in this adaptation.
May 10, 2021
Eleven individuals, and one team of 14 earned recognition for their exceptional contributions to research, teaching, and Extension. They were celebrated last week as the 2021 Faculty and Staff Award Winners in WSU’s College of Agricultural, Human, and Natural Resource Sciences.
Administrative Professional Excellence Award
Heather MacDermott Havey, director of the WSU Children’s Center, is responsible for the daily operations of the Center, including fiscal sustainability, family engagement, and child outcomes.
AP Technical Staff Excellence Award
Jennifer Kiser, a lab manager in the Department of Animal Sciences, first arrived at WSU in 2013 to pursue a master’s degree and was offered the lab manager position. She continues the research she enjoys and works with students.
Published: May 10, 2021
AUSTIN, Texas, May 10, 2021 (GLOBE NEWSWIRE) Cassava Sciences Inc., (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the initiation of a Cognition Maintenance Study (CMS) to evaluate simufilam in patients with Alzheimer’s disease. Simufilam is a drug candidate that seeks to reduce neurodegeneration and neuroinflammation. Cassava Sciences believes the ability to impact more than one aspect of Alzheimer’s disease represents a new and crucial approach to treatment.
“We’ve observed good safety and cognitive improvements in study participants treated with open-label simufilam,” said Remi Barbier, President & CEO. “The CMS is a randomized, controlled study designed to evaluate changes in cognition over six months in study participants who continue with drug treatment versus those who stop treatment. We believe clinical data from the CMS may inform the benefit-risk assessments that drive reg
2020 2016 2014 2014 2013 2013 2012 Presenilin-null cells have altered two-pore calcium channel expression and lysosomal calcium: implications for lysosomal function, Brain Research 2012 The Probability of Triggering Calcium Puffs Is Linearly Related to the Number of Inositol Trisphosphate Receptors in a Cluster, Biophysical Journal 2011 Transient receptor potential mucolipin 1 (TRPML1) and two-pore channels are functionally independent organellar ion channels, Journal of Biological Chemistry 2010 Deviant nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca2+ signaling upon lysosome proliferation, Journal of Biological Chemistry 2006 2005 2004 2003 Modulation of NAADP (nicotinic acid-adenine dinucleotide phosphate) receptors by K+ ions: evidence for multiple NAADP rec